Undifferentiated Carcinoma Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Vinorelbine in Relapsed Platinum Resistant or Refractory C5 High Grade Serous, Endometrioid, or Undifferentiated Primary Peritoneum, Fallopian Tube or Ovarian Cancer
Conditions: Ovarian Cancer; Fallopian Tube Cancer Intervention: Drug: Vinorelbine Sponsors: National University Hospital, Singapore; National Cancer Centre, Singapore; KK Women's and Children's Hospital Not yet recruiting - verified March 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 16, 2017 Category: Research Source Type: clinical trials
